EGFR and Hypomagnesemia: It is not possible to provide recommendations based on tests for administration and dosing of Mg during or after treatment with CDDP or anti-EGFR mAb, but all authors reviewed agree that hypomagnesemia must be corrected (level of evidence IV, grade of recommendation D).